ConductScience.org, home

Paper39741663

Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review.

Skrobucha A and 4 others. Front Cardiovasc Med, 2024. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review. Papers, record 39741663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39741663

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review.
PubMed
Journal
Front Cardiovasc Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
4.52, provisional
iCite
Revised in PubMed
2025-01-04
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Skrobucha AAlicja
2Pindlowski PPatryk
3Krajewska NNatalia
4Grabowski MMarcin
5Jonik SSzymon

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135400496Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis.Atherosclerosis2022https://conductscience.org/library/papers/35400496PubMed
223868944
Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Arterioscler Thromb Vasc Biol2013https://conductscience.org/library/papers/23868944PubMed
334356845Inflammatory Mechanisms Contributing to Endothelial Dysfunction.Biomedicines2021https://conductscience.org/library/papers/34356845PubMed
419195607Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.J Am Coll Cardiol2009https://conductscience.org/library/papers/19195607PubMed
536799940Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.Eur J Prev Cardiol2023https://conductscience.org/library/papers/36799940PubMed
637522848Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy.Endocr Connect2023https://conductscience.org/library/papers/37522848PubMed
719955250Chronic coronary artery disease: diagnosis and management.Mayo Clin Proc2009https://conductscience.org/library/papers/19955250PubMed
831446075New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling.J Mol Biol2020https://conductscience.org/library/papers/31446075PubMed
924267262Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice.Atherosclerosis2013https://conductscience.org/library/papers/24267262PubMed
1026630143Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.N Engl J Med2015https://conductscience.org/library/papers/26630143PubMed
1131447282Inflammation in atherosclerosis: A key role for cytokines.Cytokine2019https://conductscience.org/library/papers/31447282PubMed
1227110066Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.Mediators Inflamm2016https://conductscience.org/library/papers/27110066PubMed
1315616022Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.Diabetes2005https://conductscience.org/library/papers/15616022PubMed
1420068138Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.Diabetes2010https://conductscience.org/library/papers/20068138PubMed
1536317383Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors.Coron Artery Dis2023https://conductscience.org/library/papers/36317383PubMed
1631002893GLP-1: Molecular mechanisms and outcomes of a complex signaling system.Neurochem Int2019https://conductscience.org/library/papers/31002893PubMed
1730291013Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.Lancet2018https://conductscience.org/library/papers/30291013PubMed
1831270216Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.J Pharmacol Exp Ther2019https://conductscience.org/library/papers/31270216PubMed
1926447224The physiological role of glucagon-like peptide-1 in the regulation of renal function.Am J Physiol Renal Physiol2016https://conductscience.org/library/papers/26447224PubMed
2031185157Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med2019https://conductscience.org/library/papers/31185157PubMed

See all 49 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42923701The role of inflammation on coronary microvascular dysfunction and potential therapeutic targets.Eur Heart J Open2026https://conductscience.org/library/papers/42923701PubMed
42781074Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review.Clin Interv Aging2026https://conductscience.org/library/papers/42781074PubMed
42534427Beyond glycemic control: clinical cardiovascular effects of tirzepatide-a narrative review.Ther Adv Endocrinol Metab2026https://conductscience.org/library/papers/42534427PubMed
42105046Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.Diabetes Ther2026https://conductscience.org/library/papers/42105046PubMed
42041268Glucagon-like Peptide-1 Receptor Agonist Therapy and Risk of Pulmonary and Systemic Infections in Diabetic Gastroparesis: A Propensity-Matched Cohort Study.Adv Respir Med2026https://conductscience.org/library/papers/42041268PubMed
41879791Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.JAMA Cardiol2026https://conductscience.org/library/papers/41879791PubMed
41828519Oncometabolites and Hypoxia-Regulated Exosomes Shape HIF-Driven Macrophage Programs Across Type 2 Diabetes, Atherosclerosis, and Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/41828519PubMed
41751159Exploratory Analysis of Circulating GLP-1, GIP, and TMAO in Relation to Coronary Artery Disease Severity in Patients with Exertional Angina.Biomedicines2026https://conductscience.org/library/papers/41751159PubMed
41665655GLP-1 receptor agonists after ACS in diabetes: credible plaque signals, but comparators, confounding, and access will decide impact.Acta Diabetol2026https://conductscience.org/library/papers/41665655PubMed
41551027Do GLP-1 agonists affect perioperative risk in spine surgery? A systematic review and meta-analysis.N Am Spine Soc J2026https://conductscience.org/library/papers/41551027PubMed
41511355Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets.Cells2025https://conductscience.org/library/papers/41511355PubMed
41482411Anti-inflammatory Pathways of Novel Anti-diabetic Therapies. A Literature Review.In Vivo2026https://conductscience.org/library/papers/41482411PubMed
41392086Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trial.Nat Commun2025https://conductscience.org/library/papers/41392086PubMed
41378487Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.J Am Heart Assoc2025https://conductscience.org/library/papers/41378487PubMed
41378166Precision cardiovascular medicine: shifting the innovation paradigm.Front Sci2025https://conductscience.org/library/papers/41378166PubMed
41301689Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction.Biomedicines2025https://conductscience.org/library/papers/41301689PubMed
41286370The obesity-inflammation axis in psoriatic disease: mechanisms and therapeutic strategies.Nat Rev Rheumatol2026https://conductscience.org/library/papers/41286370PubMed
41155741Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 Cardiomyocytes.Medicina (Kaunas)2025https://conductscience.org/library/papers/41155741PubMed
40872593Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872593PubMed
40735319GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation.Front Immunol2025https://conductscience.org/library/papers/40735319PubMed

See all 21 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39741663

GET https://conductscience.org/api/papers/v1/39741663/references?page=2